ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0041

Vascularized ‘Synovium-on-a-Chip’ – A Novel and Adaptable Model for Dissecting Inflammatory Biology Underlying Rheumatoid Arthritis

Theresa Wampler Muskardin1, Chao Ma2, Benteng Ma2, Kayla Van Buren3, Timothy Niewold4 and Weiqiang Chen2, 1Colton Center for Autoimmunity, NYU School of Medicine, New York, NY, 2New York University, New York, NY, 3Mnemo Therapeutics, New York, NY, 4Colton Center for Autoimmunity NYU School of Medicine, New York, NY

Meeting: ACR Convergence 2021

Keywords: Fibroblasts, Synovial, Monocytes/macrophages, Organotypic culture system, rheumatoid arthritis, Tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Session Title: RA – Etiology & Pathogenesis Poster (0011–0045)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Rheumatoid arthritis (RA) is a common multisystem inflammatory condition, affecting approximately 1% of the world population. The mechanisms underlying RA are still incompletely defined and current therapies, such as TNF-alpha inhibition, are mainly applied to mitigate the abnormal inflammation with limited success. RA fibroblast-like synoviocytes (FLS) in the synovium release cytokines that drive inflammation and attract immune cells, particularly monocytes, to the synovium microenvironment. These monocytes can further polarize to inflammatory macrophages, exacerbate the tissue inflammation and contribute to joint destruction. Herein, we engineered an organotypic, perfusable ‘Synovium-on-a-Chip’ to recapitulate the in vivo pathophysiology of RA synovial microenvironments and to dissect the RA FLS and monocyte associated inflammatory mechanisms that contribute to RA.

Methods: The microfluidic Synovium-on-a-Chip was constructed using a polydimethylsiloxane (PDMS)-based soft lithography technique. The chip contains two areas (Fig. 1A). The inner ring was infused with endothelial cells to form a 3D vascularized sublining layer. The outer ring was inoculated with RA FLS which aligned to form a synovial lining layer in a fibrin hydrogel (Fig. 1B-D). Monocytes were isolated from peripheral blood mononuclear cells and then loaded into the 3D vasculature (Fig. 1C). We analyzed cellular architecture and motility, gene expression, and cytokine secretion. Flow cytometry was used to assess cells after culture.

Results: We found that RA FLS released several cytokines, such as IL-6, CCL5, and CCL8, which facilitate the monocyte recruitment and drive inflammation in the RA niche (Fig. 1D). We confirmed that TNF-α (a major pathogenic cytokine in RA) induced inflammatory cytokine production and enhanced monocyte migration in the inflammatory environment (Fig. 1E). We also observed RA FLS and TNF-α treatment enhanced intermediate/non-classical CD16+ monocyte emergence (Fig. 1F).

Conclusion: We engineered a biomimetic ‘Synovium-on-a-Chip’ system that reconstitutes in vivo RA pathophysiology and dissected interactions between RA FLS and peripheral blood monocytes and their associated inflammatory milieu involved in RA. To our knowledge, ours is the first vascularized device used in biomimetic synovial culture and testing.

Figure 1. An organotypic Synovium-on-a-Chip. (A) Schematic of the RA niche and microfluidic design and (B) the resultant RA chip. (C) 3D view of monocytes loaded into the vascular network. (D) Cytokine profile of the RA niche identified inflammatory cytokines. (E) Migration trajectory of monocyte into RA niche treated with or without TNF-α. (F) TNF-α promoted non-classical monocyte emergence. **p < 0.01.


Disclosures: T. Wampler Muskardin, None; C. Ma, None; B. Ma, None; K. Van Buren, None; T. Niewold, None; W. Chen, None.

To cite this abstract in AMA style:

Wampler Muskardin T, Ma C, Ma B, Van Buren K, Niewold T, Chen W. Vascularized ‘Synovium-on-a-Chip’ – A Novel and Adaptable Model for Dissecting Inflammatory Biology Underlying Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/vascularized-synovium-on-a-chip-a-novel-and-adaptable-model-for-dissecting-inflammatory-biology-underlying-rheumatoid-arthritis/. Accessed February 4, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascularized-synovium-on-a-chip-a-novel-and-adaptable-model-for-dissecting-inflammatory-biology-underlying-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences